Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kazuhisa Fukuishi"'
Autor:
Airi Fujimoto, Gouji Toyokawa, Yoshimichi Koutake, Shigeru Kimura, Yosei Kawamata, Kazuhisa Fukuishi, Koji Yamazaki, Sadanori Takeo
Publikováno v:
Thoracic Cancer, Vol 12, Iss 15, Pp 2198-2204 (2021)
Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced or recurrent non‐small cell lung cancer (NSCLC). They cause immune‐related adverse events (irAEs), but the underlying mechanisms and predictors
Externí odkaz:
https://doaj.org/article/4f32ce535f44446bb8f92289d5998f61
Autor:
Yosei Kawamata, Koji Yamazaki, Gouji Toyokawa, Sadanori Takeo, Kazuhisa Fukuishi, Yoshimichi Koutake, Shigeru Kimura, Airi Fujimoto
Publikováno v:
Thoracic Cancer, Vol 12, Iss 15, Pp 2198-2204 (2021)
Thoracic Cancer
Thoracic Cancer
Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced or recurrent non‐small cell lung cancer (NSCLC). They cause immune‐related adverse events (irAEs), but the underlying mechanisms and predictors remain to
Publikováno v:
Tetrahedron. 60:3273-3282
A new synthetic method of (−)-vallesamidine, including a unique 2,2,3-trialkylindoline skeleton, was developed by reductive radical cyclization reaction from the 2,3-dialkylindole derivative, which has been known to be an intermediate for the synth
Publikováno v:
Tetrahedron Letters. 43:2385-2388
A new synthetic method of (−)-vallesamidine, including a unique 2,2,3-trialkylindoline skeleton, is developed by reductive radical cyclization reaction from the 2,3-dialkylindole derivative, which has been known to be an intermediate for the synthe
Publikováno v:
ChemInform. 33
A new synthetic method of (−)-vallesamidine, including a unique 2,2,3-trialkylindoline skeleton, is developed by reductive radical cyclization reaction from the 2,3-dialkylindole derivative, which has been known to be an intermediate for the synthe